期刊
CHEST
卷 159, 期 3, 页码 E131-E135出版社
ELSEVIER
DOI: 10.1016/j.chest.2020.10.003
关键词
emphysema; filamin A; mutation
Emphysema is a chronic respiratory disorder characterized by destruction of alveoli, usually caused by smoking or exposure to noxious particles or gases. Dysfunctions in proteins related to lung development and maintenance can also contribute to emphysema. Identifying new risk factors for emphysema can lead to screening, prevention, and monitoring efforts, as well as genetic testing in early-onset emphysema cases.
Emphysema is a chronic respiratory disorder characterized by destruction of alveoli, usually due to cigarette smoking or exposure to noxious particles or gases. Dysfunction of proteins that are involved in lung development and maintenance, such as alpha-1 antitrypsin, also contributes to emphysema. Filamin A (FLNA) is an actin-binding protein involved in cytoskeleton reorganization. Mutations in the FLNA gene classically lead to abnormal neuronal migration and connective and vascular tissue anomalies. Pulmonary manifestations consist of a wide range of pulmonary disorders that occur during infancy. We report the first familial case of emphysema in non- and very low-smoking adults who carry a loss-of-function mutation of the FLNA gene. The identification of this new risk factor for emphysema encourages (1) screening, prevention and monitoring of pulmonary disorders in patients with FLNA mutation and (2) screening for FLNA mutation in patients with early-onset emphysema that is associated with low-smoking or vascular or connective tissue anomalies.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据